{"ticker": {"uuid": "3b8127f4-3e00-42a9-a0ee-374aafd79660", "symbol": "GSS", "name": "Genetic Signatures Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Enterprise value to revenue forward of Genetic Signatures Ltd. \u2013 ASX:GSS", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNV3Q5RUtLZktoYzV2NWh0QWVOU2xYd1hNMlNSNjhGeFYwSEc3Y3Z4TkkzcHhISEZzZ0diTnlRR1dDRjVjRzlKX3ZxNnBNVGU0a3V5Si1rcU5lSjdpUGhNYVIxZldvbUhfWTNlTVZEdjlPRmxYOUZIcjcxZ1VBUFZ1NTdMMnhEdzhEZ28yMmZOV195cEp3Z1IzN1Z3SlZGX29KR3ppV2hXYw?oc=5", "source_name": "TradingView", "published_at": "2026-07-16T13:14:04+00:00", "published_display": "16 Jul 2026 13:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures (ASX: GSS) Bounces 8% But Remains a Major Loser Over the Year: Is the Molecular Diagnostics Company Near a Floor?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxQYUJrTU1QYWJHOElFVndYS0RrODY2X29ZU3pJMVNpVGlQb3BTdW16WlpneGI2d2ZaWm0tQU5hZ1k0ZjhVVXEwMEpfQlctdkNRbGYyUUpqZGZuYmNFTlFfUE5ZOWtsckRhU20xa2lWWm9BemdGODEzcVQxSE1yQTR6WWl6ZThRb1pvTnlLZEpBckdHZXAzc29jOTJfQnotc1NGN3FJZlJnX294anBSaFpJODctc3BsUllTa2ZRVXNzeGtsVzRxdGE5eHpiblpNREdWLTFwX21aWHdHSk9ERFk5d2E1WnF1dXVrNzZRNk11ejJZYlM3YWtsRg?oc=5", "source_name": "Kalkine", "published_at": "2026-07-09T13:20:00+00:00", "published_display": "09 Jul 2026 13:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Crosses 10% Threshold in Genetic Signatures with $1.39 Million Share Purchase", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQOUgxdXZyOTh6dnF3Um54NkRHT0YtVVUzV1JzTDRsb3NyWnNDZUxTeU1fMV9yN28zRnJrVlJtNnQtQTJEYVpVTHMzcmhXa3hEbFphV3A2T0VHNzU5V3AyeVc3VzBSR28xb0JwWS10SFpiRkhtSkdVZDUwN2JhclZRN242RmlpRFFuNWUwbGRyVHhKMVdWWl81TkNUc01jZUZQaVBwb3IxSHRqbjdCajhNWjJfVWptNlhUR0FaWDdaaFVJXzBhNHEzS203ekNEQQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL takes stake in Genetic Signatures to broaden diagnostics capabilities", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPcFN3RXpGdUtZSDFKbmNDRVlENUh5SGxBVXctZ3NhUHdtdDVDaDd6NS1aUXNoYU8zMjJwMHdkeFpDQ1RkVDYzRlk3NVQ4X1RHWk9VV3cwbU4ySDR1S2F0akdUbmFGbzFyUEJRcFlyTUtPRk5Dak9UYU9WZmk0WDlOZU9rZm5LbEt1dWJfcHVsN1RfZk02VEtkbml2LXpjd01fVU15eDQ2ai15UlhhS2pz?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-07-02T01:19:50+00:00", "published_display": "02 Jul 2026 01:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Perennial Value Management Lifts Stake in Genetic Signatures to 14.81% Through On-Market Trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNQ09QR3VHNDVzLUwxOUh3N0ZCem8wNTNoc0dhci02Q0xaVjBzYVJsTmFadkFPVUthZnNfR0oycjVoNjlPUXpZRDFrbTRBVkNJdU5FVk1pYjZ5cmhHc1VQM0I3Qkh3VGw5UjVNbDF2QmtQczg1WjUxUUhyWWlhOWt4RWNXLXk3d2dmdVNVajIta2EycUtDSmhkSWJOUU0wMUpURThjR1BrelNaaVI2YURod1RtZWc0VUgxN2xNNl9HRk8yMHJnLVZKWXJvbHM2aXkw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures (ASX:GSS) Collapses 39% on Wednesday \u2014 What Investors Need to Know About Q3 Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxObHRLOVdDRnBhbnd4c19KY0lrem0xeFc4WHRPNEpmZmJyOXdKMFI3a1B6OUUwX2ZpS051UmZGME5CQlM3eVhXRm0zR194UGJibW9JZ1RNUGN0Z002akpIMVBTZmlvbmxMOV9MTzdRNFF0blhIRm1NakpNRHhvX1Q2V1ExZThuSVdIVUhxUEMwWVA3M3JzRHJnV2VPcDBJMVhmbWpiNVBqV0tRUUdERlFpY2Y2ODc5aF9SRHlmejM3Qnp3R2tUSkRvcW9icEEtMXhGZk1iZzh6Yw?oc=5", "source_name": "Kalkine", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures (ASX: GSS) Rebounds Amid International Expansion Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPNXJrZU5nM3VHMVVJZkVRSUVMU1dPRE96N1ZvTWV0MkZDRndOT29qR3ktR0QtTWQzRW1DSk5NT05vTXgyOE0zUG1zUy1XOFJmWVd3NzJYdldwa3luUFBIOGhmMmRxZXV4RUZmbS0zN193djR6Z1J5ZFN5TEVZZlVUM25PYWRCMmphMUJtRHgxZ1VjZTBHY1U0QnZxaThRVGd3ZDI0YUR5SEFRRzhRRlFaZzhCaw?oc=5", "source_name": "Kalkine", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Runners of the Week: Bison, Genetic Signatures, Narryer & Immutep", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The West Australian", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Genetic Signatures (ASX:GSS) Is Up 22% on Wednesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNdGpHTjJiRzZzSnVwZ0RJQ1ltRC0zblhXOFBTTC1qWWJpRmR1REFMN2JMY1RaR3k1YTk0a25KUHZMdjFpdGJKU093UmRfazVMV09UWmJCT1hVbFVPeThUOFJndUszb0EyUm4yc25DT1F6TEtVUVpHazZUM3BSQVY4SFY4SW90VEdyQmVlM1N4a1o5WnFk?oc=5", "source_name": "Kalkine", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures reshapes its business to cut costs and drive growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQN0xPTk1pNWxjVzFrX0hiRDUxR2dGSWlRWFBWWkx1M2h4aVVHV0ZWcGNNeUFYbVFHNnVqQkNTM3ZnVGV0eTZDQ1FPUHFVVTBkOW1fdkhKS0gtZk5CNks1b2U4UkMwSVdOaEFZdXQ4NG03T1k1cW1aMGtMampIbW9BU1V0eW9GRlN5V1FicFdacHUxRnh4N2lXdWhxZWdDOVd6LUg3VDVpMTdTZw?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Slammed 26% Genetic Signatures Limited (ASX:GSS) Screens Well Here But There Might Be A Catch", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Not Very Worried About Genetic Signatures' (ASX:GSS) Cash Burn Rate", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Not Too Worried About Genetic Signatures' (ASX:GSS) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9ONHVZLThObExSN0dsODAtVnJwTXBodjRQZTJjR094N1l2bzRIRWRRZDRweF9qdGphTEdnQllTQ080amJUZFlBV1NabmFRYW9CUVR0eUltaExvU2dZOHp4M3Bsanc4QkNKNk84bEwzNDhJbkxyWWVr?oc=5", "source_name": "Market source", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Genetic Signatures Ltd (ASX:GSS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBhT0djRjl6Z3hPWUR6blpyZVZlTmhscWJnZzNZS2J6Wmp3M001UnkwTk1IeXNSc1hITldkSzZ6OWJCM1Q1M29tLV9WS0dycWx6?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T17:38:44+00:00", "published_display": "30 Oct 2025 17:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures (ASX: GSS) Soars 47% on Record Quarterly Sales", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE1tQnZxRTlkTk83Y0VEQUdfNmE2bXc5eTFpenUtUm5xRnl2Z3NvX05FTXVsM05VbHhXY0MxX2djeGJUQy1xNXFULW9sOVBoR25mOG5BdGJkSFllbjQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-10-21T07:00:00+00:00", "published_display": "21 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures launching GI parasite test in US following clearance", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOQ1VzUnlBNFZjS3hnYXktS2pwczF1c3g2SzJhY1ppZ3ZLRFhJVGxOZ0lVSU9sbE1HaEZIaUcyRi1DX0ZZUXA0aHozTkhFN3g5WmhPRDhTLU1SOWtyeHgwalZDNDBkemZRQnVxaVg4bVFXVDh1dTltOGduaHdfSzVwZkRyRE9ZZ29yLURLQUxVUFFVc0hwMnVGVGc3WFpqUGVpZ0plWWRTVHh2dWV4Ui1JSVlR?oc=5", "source_name": "BioWorld News", "published_at": "2024-06-05T07:00:00+00:00", "published_display": "05 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enterprise value to revenue forward of Genetic Signatures Ltd. \u2013 ASX:GSS", "summary": "", "url": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNV3Q5RUtLZktoYzV2NWh0QWVOU2xYd1hNMlNSNjhGeFYwSEc3Y3Z4TkkzcHhISEZzZ0diTnlRR1dDRjVjRzlKX3ZxNnBNVGU0a3V5Si1rcU5lSjdpUGhNYVIxZldvbUhfWTNlTVZEdjlPRmxYOUZIcjcxZ1VBUFZ1NTdMMnhEdzhEZ28yMmZOV195cEp3Z1IzN1Z3SlZGX29KR3ppV2hXYw?oc=5", "source_name": "TradingView", "published_at": "2026-07-16T13:14:04+00:00", "published_display": "16 Jul 2026 13:14", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures (ASX: GSS) Bounces 8% But Remains a Major Loser Over the Year: Is the Molecular Diagnostics Company Near a Floor?", "summary": "", "url": "https://news.google.com/rss/articles/CBMi-AFBVV95cUxQYUJrTU1QYWJHOElFVndYS0RrODY2X29ZU3pJMVNpVGlQb3BTdW16WlpneGI2d2ZaWm0tQU5hZ1k0ZjhVVXEwMEpfQlctdkNRbGYyUUpqZGZuYmNFTlFfUE5ZOWtsckRhU20xa2lWWm9BemdGODEzcVQxSE1yQTR6WWl6ZThRb1pvTnlLZEpBckdHZXAzc29jOTJfQnotc1NGN3FJZlJnX294anBSaFpJODctc3BsUllTa2ZRVXNzeGtsVzRxdGE5eHpiblpNREdWLTFwX21aWHdHSk9ERFk5d2E1WnF1dXVrNzZRNk11ejJZYlM3YWtsRg?oc=5", "source_name": "Kalkine", "published_at": "2026-07-09T13:20:00+00:00", "published_display": "09 Jul 2026 13:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Crosses 10% Threshold in Genetic Signatures with $1.39 Million Share Purchase", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQOUgxdXZyOTh6dnF3Um54NkRHT0YtVVUzV1JzTDRsb3NyWnNDZUxTeU1fMV9yN28zRnJrVlJtNnQtQTJEYVpVTHMzcmhXa3hEbFphV3A2T0VHNzU5V3AyeVc3VzBSR28xb0JwWS10SFpiRkhtSkdVZDUwN2JhclZRN242RmlpRFFuNWUwbGRyVHhKMVdWWl81TkNUc01jZUZQaVBwb3IxSHRqbjdCajhNWjJfVWptNlhUR0FaWDdaaFVJXzBhNHEzS203ekNEQQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL takes stake in Genetic Signatures to broaden diagnostics capabilities", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPcFN3RXpGdUtZSDFKbmNDRVlENUh5SGxBVXctZ3NhUHdtdDVDaDd6NS1aUXNoYU8zMjJwMHdkeFpDQ1RkVDYzRlk3NVQ4X1RHWk9VV3cwbU4ySDR1S2F0akdUbmFGbzFyUEJRcFlyTUtPRk5Dak9UYU9WZmk0WDlOZU9rZm5LbEt1dWJfcHVsN1RfZk02VEtkbml2LXpjd01fVU15eDQ2ai15UlhhS2pz?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-07-02T01:19:50+00:00", "published_display": "02 Jul 2026 01:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Perennial Value Management Lifts Stake in Genetic Signatures to 14.81% Through On-Market Trades", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNQ09QR3VHNDVzLUwxOUh3N0ZCem8wNTNoc0dhci02Q0xaVjBzYVJsTmFadkFPVUthZnNfR0oycjVoNjlPUXpZRDFrbTRBVkNJdU5FVk1pYjZ5cmhHc1VQM0I3Qkh3VGw5UjVNbDF2QmtQczg1WjUxUUhyWWlhOWt4RWNXLXk3d2dmdVNVajIta2EycUtDSmhkSWJOUU0wMUpURThjR1BrelNaaVI2YURod1RtZWc0VUgxN2xNNl9HRk8yMHJnLVZKWXJvbHM2aXkw?oc=5", "source_name": "Kalkine", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures (ASX:GSS) Collapses 39% on Wednesday \u2014 What Investors Need to Know About Q3 Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxObHRLOVdDRnBhbnd4c19KY0lrem0xeFc4WHRPNEpmZmJyOXdKMFI3a1B6OUUwX2ZpS051UmZGME5CQlM3eVhXRm0zR194UGJibW9JZ1RNUGN0Z002akpIMVBTZmlvbmxMOV9MTzdRNFF0blhIRm1NakpNRHhvX1Q2V1ExZThuSVdIVUhxUEMwWVA3M3JzRHJnV2VPcDBJMVhmbWpiNVBqV0tRUUdERlFpY2Y2ODc5aF9SRHlmejM3Qnp3R2tUSkRvcW9icEEtMXhGZk1iZzh6Yw?oc=5", "source_name": "Kalkine", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures (ASX: GSS) Rebounds Amid International Expansion Signals", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPNXJrZU5nM3VHMVVJZkVRSUVMU1dPRE96N1ZvTWV0MkZDRndOT29qR3ktR0QtTWQzRW1DSk5NT05vTXgyOE0zUG1zUy1XOFJmWVd3NzJYdldwa3luUFBIOGhmMmRxZXV4RUZmbS0zN193djR6Z1J5ZFN5TEVZZlVUM25PYWRCMmphMUJtRHgxZ1VjZTBHY1U0QnZxaThRVGd3ZDI0YUR5SEFRRzhRRlFaZzhCaw?oc=5", "source_name": "Kalkine", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ASX Runners of the Week: Bison, Genetic Signatures, Narryer & Immutep", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The West Australian", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Genetic Signatures (ASX:GSS) Is Up 22% on Wednesday?", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNdGpHTjJiRzZzSnVwZ0RJQ1ltRC0zblhXOFBTTC1qWWJpRmR1REFMN2JMY1RaR3k1YTk0a25KUHZMdjFpdGJKU093UmRfazVMV09UWmJCT1hVbFVPeThUOFJndUszb0EyUm4yc25DT1F6TEtVUVpHazZUM3BSQVY4SFY4SW90VEdyQmVlM1N4a1o5WnFk?oc=5", "source_name": "Kalkine", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures reshapes its business to cut costs and drive growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQN0xPTk1pNWxjVzFrX0hiRDUxR2dGSWlRWFBWWkx1M2h4aVVHV0ZWcGNNeUFYbVFHNnVqQkNTM3ZnVGV0eTZDQ1FPUHFVVTBkOW1fdkhKS0gtZk5CNks1b2U4UkMwSVdOaEFZdXQ4NG03T1k1cW1aMGtMampIbW9BU1V0eW9GRlN5V1FicFdacHUxRnh4N2lXdWhxZWdDOVd6LUg3VDVpMTdTZw?oc=5", "source_name": "BiotechDispatch", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Slammed 26% Genetic Signatures Limited (ASX:GSS) Screens Well Here But There Might Be A Catch", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-22T08:00:00+00:00", "published_display": "22 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "We're Not Very Worried About Genetic Signatures' (ASX:GSS) Cash Burn Rate", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-15T08:00:00+00:00", "published_display": "15 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why We're Not Too Worried About Genetic Signatures' (ASX:GSS) Cash Burn Situation", "summary": "", "url": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9ONHVZLThObExSN0dsODAtVnJwTXBodjRQZTJjR094N1l2bzRIRWRRZDRweF9qdGphTEdnQllTQ080amJUZFlBV1NabmFRYW9CUVR0eUltaExvU2dZOHp4M3Bsanc4QkNKNk84bEwzNDhJbkxyWWVr?oc=5", "source_name": "Market source", "published_at": "2026-01-10T08:00:00+00:00", "published_display": "10 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insights: Genetic Signatures Ltd (ASX:GSS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTFBhT0djRjl6Z3hPWUR6blpyZVZlTmhscWJnZzNZS2J6Wmp3M001UnkwTk1IeXNSc1hITldkSzZ6OWJCM1Q1M29tLV9WS0dycWx6?oc=5", "source_name": "smallcaps.com.au", "published_at": "2025-10-30T17:38:44+00:00", "published_display": "30 Oct 2025 17:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures (ASX: GSS) Soars 47% on Record Quarterly Sales", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE1tQnZxRTlkTk83Y0VEQUdfNmE2bXc5eTFpenUtUm5xRnl2Z3NvX05FTXVsM05VbHhXY0MxX2djeGJUQy1xNXFULW9sOVBoR25mOG5BdGJkSFllbjQ?oc=5", "source_name": "Stocks Down Under", "published_at": "2025-10-21T07:00:00+00:00", "published_display": "21 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Genetic Signatures launching GI parasite test in US following clearance", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxOQ1VzUnlBNFZjS3hnYXktS2pwczF1c3g2SzJhY1ppZ3ZLRFhJVGxOZ0lVSU9sbE1HaEZIaUcyRi1DX0ZZUXA0aHozTkhFN3g5WmhPRDhTLU1SOWtyeHgwalZDNDBkemZRQnVxaVg4bVFXVDh1dTltOGduaHdfSzVwZkRyRE9ZZ29yLURLQUxVUFFVc0hwMnVGVGc3WFpqUGVpZ0plWWRTVHh2dWV4Ui1JSVlR?oc=5", "source_name": "BioWorld News", "published_at": "2024-06-05T07:00:00+00:00", "published_display": "05 Jun 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 83, "total_relevant": 16, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 14, "score": 52, "total": 16, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 6.05, "count": 11}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 2, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.06, "latest_week": "2026-07-10", "one_week_move": -5.9, "four_week_move": -13.5, "twelve_week_move": -61.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.416223, "market_dynamics_buy_signal": false, "relative_strength": -67.079595, "fair_value_gap": -85.9, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 31.1581, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-5.9% over one week, -13.5% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 6}, {"label": "BiotechDispatch", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "TradingView", "count": 1}, {"label": "The West Australian", "count": 1}, {"label": "Market source", "count": 1}, {"label": "smallcaps.com.au", "count": 1}, {"label": "Stocks Down Under", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 16}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 11}, {"label": "Deals and strategy", "count": 2}, {"label": "Balance sheet", "count": 2}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "16", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-5.9% over one week, -13.5% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Enterprise value to revenue forward of Genetic Signatures Ltd. \u2013 ASX:GSS"}], "updated_at": "2026-07-17T05:00:19.222100+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}